# Efficacy, Safety, and Biomarkers of Toripalimab in Patients with Recurrent or Metastatic Neuroendocrine Neoplasms: A Multiple-Center Phase Ib Trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-safety-and-biomarkers-of-toripalimab-in-patients-with-recurrent-or/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Ming Lu,Panpan Zhang,Yanqiao Zhang,Zhongwu Li,Jifang Gong,Jie Li,Jian Li,Yan Li,Xiaotian Zhang,Zhihao Lü,Xicheng Wang,Jun Zhou,Zhi Peng,Weifeng Wang,Hui Feng,Hai Wu,Sheng Yao,Lin Shen |
| Citations | 114 |
| DOI | 10.1158/1078-0432.ccr-19-4000 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3008867012 |
| PMID | 32086343 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Yan Li](https://scholariq.org/researchers/yan-li/)

## Paper journal

- [Clinical Cancer Research](https://scholariq.org/journals/clinical-cancer-research/)

## Paper primary topic

- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)

## Paper topics

- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Cutaneous Melanoma Detection and Management](https://scholariq.org/topics/cutaneous-melanoma-detection-and-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.